Radient Pharmaceuticals (RPC) Down 8% After Response to J&J Cancer Test
Go back to Radient Pharmaceuticals (RPC) Down 8% After Response to J&J Cancer Test| Johnson & Johnson (NYSE: JNJ) | Delayed: 267.37 -6.04 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $273.41 | 52 Week High | $126.07 | |||
| Open | $273.40 | 52 Week Low | $94.28 | |||
| Day High | $273.40 | P/E | 55.59 | |||
| Day Low | $267.37 | EPS | $4.81 | |||
| Volume | 6,474,884 | |||||
| Radient Pharmaceuticals (NYSE: RPC) | Delayed: 8.63 -0.07 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.70 | 52 Week High | $1.69 | |||
| Open | $8.68 | 52 Week Low | $0.14 | |||
| Day High | $8.71 | P/E | N/A | |||
| Day Low | $8.54 | EPS | $-3.02 | |||
| Volume | 384,764 | |||||
